ESSA Pharma Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ESSA Pharma Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
  • ESSA Pharma Inc. Debt-to-equity for the quarter ending September 30, 2024 was 2.95 %, a 49.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.95 +0.98 +49.9% Sep 30, 2024
Q2 2024 2.83 +1.11 +64.5% Jun 30, 2024
Q1 2024 2.66 +0.88 +49.5% Mar 31, 2024
Q4 2023 2.17 +0.2 +10.1% Dec 31, 2023
Q3 2023 1.96 -0.08 -3.92% Sep 30, 2023
Q2 2023 1.72 -0.48 -21.8% Jun 30, 2023
Q1 2023 1.78 -0.3 -14.4% Mar 31, 2023
Q4 2022 1.97 -0.13 -6.19% Dec 31, 2022
Q3 2022 2.04 -0.14 -6.43% Sep 30, 2022
Q2 2022 2.21 +0.09 +4.25% Jun 30, 2022
Q1 2022 2.08 Mar 31, 2022
Q4 2021 2.1 Dec 31, 2021
Q3 2021 2.18 Sep 30, 2021
Q2 2021 2.12 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.